TMA secondary to SLE: rituximab improves overall but not renal survival.

about

TMA secondary to SLE: rituximab improves overall but not renal survival.

Item

http://www.wikidata.org/entity/Q38601065

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

TMA secondary to SLE: rituximab improves overall but not renal survival.

@en

type

Item

label

TMA secondary to SLE: rituximab improves overall but not renal survival.

@en

prefLabel

TMA secondary to SLE: rituximab improves overall but not renal survival.

@en

P1476

TMA secondary to SLE: rituximab improves overall but not renal survival.

@en

P2093

Fangfang Sun

http://www.w3.org/2001/XMLSchema#string

Kaiwen Wang

http://www.w3.org/2001/XMLSchema#string

Shuang Ye

http://www.w3.org/2001/XMLSchema#string

Ting Li

http://www.w3.org/2001/XMLSchema#string

Wanlong Wu

http://www.w3.org/2001/XMLSchema#string

Xiaodong Wang

http://www.w3.org/2001/XMLSchema#string

Zhiwei Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties

Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse.

[Thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus].

Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus.

Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.

TTP/HUS and prognosis: the syndrome and the disease(s).

A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus.

Rituximab therapy to prevent relapse in chronic relapsing thrombotic thrombocytopenic purpura (TTP) in a child.

Successful prevention of thrombotic thrombocytopenic purpura (TTP) relapse using monthly prophylactic plasma exchanges throughout pregnancy in a patient with systemic lupus erythematosus and a prior history of refractory TTP and recurrent fetal loss

Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13.

P31

scholarly article

P356

10.1007/S10067-017-3793-4

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28856466

http://www.w3.org/2001/XMLSchema#string